Skip to search formSkip to main contentSkip to account menu

low-density lipoprotein particle receptor catabolic process

Known as: LDL receptor catabolism, low-density lipoprotein receptor breakdown, LDL receptor breakdown 
The chemical reactions and pathways resulting in the breakdown of a low-density lipoprotein particle receptor molecule, a macromolecule that… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Pathophysiology of Dyslipidemia and its Management by PCSK9 Inhibitors: A Literature Review
Dyslipidemia is a disease of abnormal lipid levels in the blood that contributes to the atherosclerotic process. This atherogenic… 
2017
2017
Association Between Plasma Proprotein Convertase Subtilisin/Kexin Type 9 and the Presence of Metabolic Syndrome in a Predominantly Rural-Based Sub-Saharan African Population.
BACKGROUND The prevalence of metabolic syndrome (MetS) has increased dramatically in low- and middle-income countries. Proprotein… 
2016
2016
Proprotein convertase subtilisin/kexin type 9 in rheumatoid arthritis.
OBJECTIVES Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a serine protease that regulates cholesterol metabolism… 
2012
2012
Abstract 12815: Hepatic Overexpression of Idol Accelerates LDL Receptor Degradation Partly by Increasing Circulating PCSK9 Levels via SREBP2/LDL Receptor-Dependent Pathways
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)